Open AccessIncidence of urticaria, angioedema, and type I hypersensitivity reactions associated with fibrinolytic agents in Thailand using the database of the health product vigilance center
Author(s) -
Hutsaya Prasitdumrong,
Kawin Duangmee,
Pornwalai Boonmuang,
Wichai Santimaleeworagun,
Yaowares Oppamayun,
Cholticha Sonsupap,
Thawatchai Nakkaratniyom
Publication year - 2023
Publication title -
asian pacific journal of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 33
ISSN - 0125-877X
DOI - 10.12932/ap-181119-0694
Subject(s) - angioedema , medicine , incidence (geometry) , anaphylaxis , hypersensitivity reaction , allergy , drug allergy , dermatology , immunology , physics , optics
Besides hemorrhage, allergic reactions have also been observed in several clinical trials of fibrinolytic agents. These reactions might negatively affect patient outcomes, especially life-threatening type I hypersensitivity reactions such as anaphylaxis. However, there are limited data on the incidence of these reactions.